Showing results (51-60 of 187) with videos related to

Sort By:
Pageof 19
Future Oncology (London, England)|August 16, 2023
Phase II biomarker identification study of anti-VEGF agents with FOLFIRI for pretreated metastatic colorectal cancerTadayoshi Hashimoto, Satoshi Otsu, Shuichi Hironaka, et al.
International Journal of Clinical Oncology|March 20, 2020
Comparison of involved field radiotherapy and elective nodal irradiation in combination with concurrent chemotherapy for T1bN0M0 esophageal cancerYukihiro Nakatani, Ken Kato, Hirokazu Shoji, et al.
Future Oncology (London, England)|September 26, 2023
A randomized phase II study comparing preoperative mFOLFOX6 versus FOLFOXIRI for locally advanced colon cancer: JCOG2006Tadayoshi Hashimoto, Satoshi Maruyama, Yasumasa Takii, et al.
Anticancer Research|September 10, 2014
Irinotecan plus cisplatin in patients with extensive-disease poorly differentiated neuroendocrine carcinoma of the esophagusHitomi Sumiyoshi Okuma, Satoru Iwasa, Hirokazu Shoji, et al.
Journal of Cancer Research and Clinical Oncology|June 4, 2016
Serum levels of soluble programmed cell death ligand 1 as a prognostic factor on the first-line treatment of metastatic or recurrent gastric cancerNaoki Takahashi, Satoru Iwasa, Yusuke Sasaki, et al.
Japanese Journal of Clinical Oncology|November 21, 2012
A phase II clinical trial of endoscopic submucosal dissection for early gastric cancer of undifferentiated type: Japan Clinical Oncology Group study JCOG1009/1010Kohei Takizawa, Atsuo Takashima, Aya Kimura, et al.
Scientific Reports|October 20, 2023
Renal impairment as a risk factor for trifluridine/tipiracil-induced adverse events in metastatic colorectal cancer patients from the REGOTAS studyMamiko Shiroyama, Shota Fukuoka, Toshiki Masuishi, et al.
Journal of Neuro-Oncology|December 2, 2008
Prognostic factors and clinical outcomes in patients with leptomeningeal metastasis from solid tumorsFusako Waki, Masashi Ando, Atsuo Takashima, et al.
Case Reports in Oncology|March 29, 2021
Panitumumab-Associated Drug-Induced Immune Thrombocytopenia in a Patient with Colorectal CancerShigemasa Takamizawa, Hirokazu Shoji, Hidekazu Hirano, et al.
Journal of Cancer Research and Clinical Oncology|September 4, 2009
Sequential chemotherapy with methotrexate and 5-fluorouracil for chemotherapy-naive advanced gastric cancer with disseminated intravascular coagulation at initial diagnosisAtsuo Takashima, Kuniaki Shirao, Yoshinori Hirashima, et al.
Pageof 19